Novartis to Buy Breast-Cancer Drug From Synnovation for Up to $3 Billion
wsj.com
Want to monitor CRNC?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor CRNCcerence (nasdaq: crnc) is the global industry leader in creating unique, moving experiences for the mobility world.